These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1456403)

  • 1. Multiple relapses of Clostridium difficile-associated diarrhea in a cancer patient. Successful control with long-term cholestyramine therapy.
    Moncino MD; Falletta JM
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):361-4. PubMed ID: 1456403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment strategies for C. difficile associated diarrhea.
    Stepan C; Surawicz CM
    Acta Gastroenterol Latinoam; 2007 Sep; 37(3):183-91. PubMed ID: 17955730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Past, present, and future therapies for Clostridium difficile-associated disease.
    Surowiec D; Kuyumjian AG; Wynd MA; Cicogna CE
    Ann Pharmacother; 2006 Dec; 40(12):2155-63. PubMed ID: 17148650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile associated diarrhea: new rules for an old game.
    Verma P; Makharia GK
    Trop Gastroenterol; 2011; 32(1):15-24. PubMed ID: 21922851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnosis and treatment of Clostridium difficile in antibiotic-associated diarrhea.
    Gorenek L; Dizer U; Besirbellioglu B; Eyigun CP; Hacibektasoglu A; Van Thiel DH
    Hepatogastroenterology; 1999; 46(25):343-8. PubMed ID: 10228818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment strategies for recurrent and refractory Clostridium difficile-associated diarrhea.
    Stepan C; Surawicz CM
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):295-305. PubMed ID: 19072422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile-associated diarrhea and chronic renal insufficiency.
    Yousuf K; Saklayen MG; Markert RJ; Barde CJ; Gopalswamy N
    South Med J; 2002 Jul; 95(7):681-3. PubMed ID: 12144071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile-associated diarrhea: risk factors, diagnostic methods, and treatment.
    Oldfield EC
    Rev Gastroenterol Disord; 2004; 4(4):186-95. PubMed ID: 15580153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacitracin treatment of antibiotic-associated colitis and diarrhea caused by Clostridium difficile toxin.
    Chang TW; Gorbach SL; Bartlett JG; Saginur R
    Gastroenterology; 1980 Jun; 78(6):1584-6. PubMed ID: 7372074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and appropriateness of empiric metronidazole for Clostridium difficile-associated diarrhea.
    Vasa CV; Glatt AE
    Am J Gastroenterol; 2003 Feb; 98(2):354-8. PubMed ID: 12591054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic-associated diarrhea and Clostridium difficile colitis: an update.
    Giannella RA
    Rev Esp Enferm Dig; 2001 Aug; 93(8):535-43. PubMed ID: 11692783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
    Aseeri M; Schroeder T; Kramer J; Zackula R
    Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nosocomial diarrhea and Clostridium Difficile associated diarrhea in a Turkish University Hospital.
    Ergen EK; Akalin H; Yilmaz E; Sinirtaş M; Alver O; Heper Y; Ozakin C; Bakker D; Ener B; Mistik R; Helvaci S; Kuijper EJ
    Med Mal Infect; 2009 Jun; 39(6):382-7. PubMed ID: 19269761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical features of Clostridium difficile-associated diarrhea in a tertiary hospital in northern Taiwan.
    Hsu MS; Wang JT; Huang WK; Liu YC; Chang SC
    J Microbiol Immunol Infect; 2006 Jun; 39(3):242-8. PubMed ID: 16783456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Length of vancomycin administration for treatment of clostridium difficile-associated diarrhea may depend on presentation of colonic ulcer.
    Yamashita M; Nomura K; Fujimoto Y; Morimoto Y; Ohshiro M; Tsutsumi Y; Kobayashi T; Kaneko H; Yasuhawa S; Yanagisawa A; Toshikazu Y; Masafumi T;
    Hepatogastroenterology; 2009; 56(90):313-6. PubMed ID: 19579589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
    Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
    Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific risk factors for Clostridium difficile-associated diarrhea: a prospective, multicenter, case control evaluation.
    Vesta KS; Wells PG; Gentry CA; Stipek WJ
    Am J Infect Control; 2005 Oct; 33(8):469-72. PubMed ID: 16216661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada.
    Pépin J; Routhier S; Gagnon S; Brazeau I
    Clin Infect Dis; 2006 Mar; 42(6):758-64. PubMed ID: 16477549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents.
    Nomura K; Fujimoto Y; Yamashita M; Morimoto Y; Ohshiro M; Sato K; Oyake T; Kowata S; Konishi H; Yoshikawa T; Ishida Y; Taniwaki M;
    Scand J Gastroenterol; 2009; 44(1):74-8. PubMed ID: 18781540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium difficile-associated diarrhoea in patients with human immunodeficiency virus infection: a case-control study.
    Tumbarello M; Tacconelli E; Leone F; Cauda R; Ortona L
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):259-63. PubMed ID: 7743309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.